Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 3251 - 3275 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▲
Diacylglycerophosphoinositolglycans LMGP15010147
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/16:0)
126457515 1458.737133 C65H119O33P
Diacylglycerophosphoinositolglycans LMGP15010158
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:0/14:0)
126457526 1458.737133 C65H119O33P
Gangliosides LMSP0601AJ05
  • GM3(d18:1/24:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262040 84681 1264.838363 C65H120N2O21
Gangliosides LMSP0601DH06
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262617 1251.843114 C65H121NO21
LMSL03001278
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R-heptamethyl)-15-hydroxy-triacontanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/30:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[R],12Me[R],14Me[R],15OH))
126457719 1208.855927 C65H124O17S
LMSL05000012
  • (11S)-jalapinolic 11-O-alpha-l-rhamnopyranosyl-(1-3)-O-[4-O-n-dodecanoyl-alpha-l-rhamnopyranosyl-(1-4)]-O-[2-O-n-octanoyl]-alpha-l-rhamnopyranosyl-(114)-O-alpha-l-rhamnopyranosyl-(1-2)-O-beta-d-fucopyranoside-(1,3''-lactone)
  • Asarifolin I
166628280 1292.78566 C66H116O24
Diacylglycerophosphoinositolglycans LMGP15010155
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(17:0/16:2(9Z,12Z))
126457523 1468.721483 C66H117O33P
Diacylglycerophosphoinositolglycans LMGP15010188
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:2(9Z,12Z)/14:0)
126457556 1468.721483 C66H117O33P
Diacylglycerophosphoinositolglycans LMGP15010154
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(17:0/16:1(9Z))
126457522 1470.737133 C66H119O33P
Diacylglycerophosphoinositolglycans LMGP15010182
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:1(9Z)/14:0)
126457550 1470.737133 C66H119O33P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI01
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260548 1372.807853 C66H120N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC01
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Lewis a(d18:1/16:0)
44260628 1372.807853 C66H120N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD01
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type I H antigen(d18:1/16:0)
44260636 1372.807853 C66H120N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB01
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Lex-5(d18:1/16:0)
44260980 1372.807853 C66H120N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD01
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type II antigen(d18:1/16:0)
44260996 1372.807853 C66H120N2O27
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AV01
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261604 1372.807853 C66H120N2O27
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE01
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • SSEA-3 antigen(d18:1/16:0)
44260196 1388.802768 C66H120N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AP01
  • GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260284 1388.802768 C66H120N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BA01
  • Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260372 1388.802768 C66H120N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BK01
  • Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260452 1388.802768 C66H120N2O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AJ01
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260556 1388.802768 C66H120N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AQ01
  • Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260740 1388.802768 C66H120N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BU01
  • Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260964 1388.802768 C66H120N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AC01
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260988 1388.802768 C66H120N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BJ01
  • Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • galgactosyl-paraglobside(d18:1/16:0)
44261252 1388.802768 C66H120N2O28

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024